ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology. read more
ImmunoGen CEO & Leadership Team Ratings
Mark Enyedy and the ImmunoGen leadership team are scored an "A+" by 9 employees placing it in the Top 5% of companies sized 501-1,000 Employees on Comparably. The Leadership Score of 83/100 is based on 32 ratings; it combines employee feedback on their CEO (84/100), Manager (78/100), and Executive Team (82/100).
Mark Enyedy ImmunoGen CEO Rating
Top 5% Compared to other companies of similar size in BostonA+
84 / 100
Mark Enyedy the CEO of ImmunoGen received an average score of 84 from ImmunoGen employees.ImmunoGen Manager Rating
Top 15% Compared to other companies of similar size in BostonA-
78 / 100
ImmunoGen Executive Team Rating
Top 5% Compared to other companies of similar size in BostonA+
82 / 100
×